Business
United Imaging Healthcare Releases 2025 ESG Report: Upgraded to MSCI "AA" Rating, Driving Sustainable Development Through Innovation
United Imaging Healthcare (SSE:688271) has released its 2025 Environmental, Social and Governance (ESG) Report, outlining the company's strategic framework, key initiatives, and long-term commitments across sustainability.
About this update from Shanghai United Imaging Healthcare Co., Ltd. Class A
[{"type":"text","content":"SHANGHAI, April 29, 2026 /PRNewswire/ -- United Imaging Healthcare (SSE:688271) has released its 2025 Environmental, Social and Governance (ESG) Report, outlining the company's strategic framework, key initiatives, and long-term commitments across sustainability.","length":267,"tagName":"p"},{"type":"text","content":"Over the past year, the company has continued to strengthen its sustainability performance. MSCI upgraded United Imaging Healthcare's ESG rating from "A" to "AA," marking the second consecutive year of advancement. Meanwhile, the company ranked among the top 10% globally in the S&P Global Corporate Sustainability Assessment (CSA) for its industry.","length":377,"tagName":"p"},{"type":"text","content":"Supported by a global installed base of over 39,000 systems and a network of more than 16,400 clinical and research institutions, United Imaging Healthcare leverages original innovation and intelligent solutions to enhance the efficiency, equity, and sustainability of healthcare systems worldwide. In 2025, the company played a key role in the establishment of the China-Africa Hospital Alliance, advancing collaboration in oncology care and digital medical imaging to enhance healthcare capacity across the region.","length":516,"tagName":"p"},{"type":"text","content":"On the innovation front, by the end of 2025, the company had launched more than 150 products globally, including 75 with EU CE certification and 58 cleared by the U.S. FDA (510(k)). Over 20 products have received FDA clearances for AI-enabled functionalities. Total patent applications have exceeded 10,000, with invention patents accounting for 82%, reinforcing the Company's leadership in high-end medical equipment.","length":422,"tagName":"p"},{"type":"text","content":"Beyond technological breakthroughs, United Imaging Healthcare is rapidly expanding its global presence to deliver innovative solutions to underserved markets worldwide. The company has forged partnerships with preeminent academic medical centers and leading healthcare providers across North America, Asia, and the Middle East, including UC Davis Health, Yale University School of Medicine, Washington University School of Medicine, King Hussein Cancer Center, Singapore General Hospital, and IHH Healthcare. These alliances reinforce its dedication to promoting e...
More updates from Shanghai United Imaging Healthcare Co., Ltd. Class A